Instruments

Name Stock exchange Average volume Price Type
COHEN & COMPANY INC. COHN

Nyse

26,110 10.68 USD Stock Cohen & Company Inc. Stock
COHEN & STEERS, INC. CNS

Nyse +3 Other

188,730 73.31 USD Stock Cohen & Steers, Inc. Stock
COHEN & STEERS, INC. FG9

Deutsche Boerse AG

- 67.5 EUR Stock Cohen & Steers, Inc.
COHEN & STEERS, INC. FG9

BOERSE MUENCHEN

- 67.5 EUR Stock Cohen & Steers, Inc.
COHEN & STEERS, INC. FG9

Börse Stuttgart

- 66.5 EUR Stock Cohen & Steers, Inc.
COHEN & STEERS INFRASTRUCTURE FUND, INC UTF

Nyse

192,727 23.57 USD Stock Cohen & Steers Infrastructure Fund, Inc Stock
COHEN DEVELOPMENT GAS & OIL LTD. CDEV

TEL AVIV STOCK EXCHANGE

3,111 10,500 ILa Stock Cohen Development Gas & Oil Ltd. Stock
COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. FOF

Nyse

60,084 11.76 USD Stock Cohen & Steers Closed-End Opportunity Fund, Inc. Stock
COHEN & STEERS TOTAL RETURN REALTY FUND, INC. RFI

Nyse

54,044 11.65 USD Stock Cohen & Steers Total Return Realty Fund, Inc. Stock
COHEN & STEERS QUALITY INCOME REALTY FUND, INC. RQI

Nyse

311,636 11.7 USD Stock Cohen & Steers Quality Income Realty Fund, Inc. Stock
COHEN & STEERS REAL ESTATE OPPORTUNITIES & INCOME FUND RLTY

Nyse

63,478 13.93 USD Stock Cohen & Steers Real Estate Opportunities & Income Fund Stock
COHEN & STEERS SELECT PREFERRED AND INCOME FUND, INC. PSF

Nyse

32,520 19.24 USD Stock Cohen & Steers Select Preferred and Income Fund, Inc. Stock
COHEN & STEERS REIT AND PREFERRED INCOME FUND, INC. RNP

Nyse

87,689 20.63 USD Stock Cohen & Steers REIT and Preferred Income Fund, Inc. Stock

News (340)

Blackstone to Acquire Majority Stake in Priority Software BU
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference AQ
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update AQ
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum AQ
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC AQ
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update AQ
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit AQ
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer AQ
Massivit Has Successfully Completed a ~USD 4.95 Million (~18 Million NIS) Capital Raising Through A Rights Issue PR
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference AQ
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024 AQ
Firering Strategic Minerals starts drilling campaign in Ivory Coast AN
Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-v8 monoclonal antibody AQ
Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601) AQ
Massivit to Present Virtually at the 26th Annual Needham Growth Conference on Friday, January 19 PR
Firering signs pact for Atex project drilling to begin next month AN
Radware Announces New Appointment to Its Board of Directors AQ
Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update AQ
Corbus Pharmaceuticals Announces Publication of Data for its Novel Cannabinoid Type-1 Receptor Inverse Agonist in a Pre-Clinical Model of Obesity Along with Presentations at Obesity Week 2023 AQ
Wix com : Notice and Proxy Statement with respect to the Company’s Annual General Meeting of Shareholders to be held on November 6, 2023 - Form 6-K PU
EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO AN
Firering Strategic posts fundraise as eyes start of drilling campaign AN
Firering Strategic begins commissioning of Zambia lime plant AN
Firering Strategic buys stake in former Glencore limestone project AN
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update AQ
Massivit to Participate in the 12th Annual Needham Industrial Tech, Robotics, & Clean Tech 1x1 Virtual Conference on August 7 PR
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference PR
Kornit Digital : NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 28, 2023 - Form 6-K PU
Fireing Strategic successfully starts phase 2 auger drilling AN
Wentworth swings to loss as M&P takeover drags on AN
Scheme of arrangement for ECSC takeover passes AN
Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference PR
Firering completes soil sampling programme; identifies pegmatite AN
Massivit to Participate in the Inaugural EF Hutton Global Conference on May 10, 2023 PR
NWF beats market view; AFC hydrogen offering progress AN
Wix Announces Changes to Board of Directors to Support New Phase of Value Creation PR
Wix Announces Changes to Its Board of Directors CI
Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update PR
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA PR
Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference PR
Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) PR
Ondas Networks Inc. and American Robotics, Inc. completed the acquisition of Airobotics Ltd.. CI
TRADING UPDATES: Galileo confirms gold zone; Spectral hails results AN
TRADING UPDATES: Serinus completes rig-up; Xtract concludes JV deal AN
Kornit Digital : NOTICE OF SPECIAL GENERAL MEETING OF SHAREHOLDERSTO BE HELD ON DECEMBER 29, 2022 - Form 6-K PU
1234NextSee all

Companies (11)

COHEN & STEERS, INC. 3 705 M $
Logo Cohen & Steers, Inc.

Cohen & Steers, Inc. is a holding company, which is engaged in global investment management. The Company is specialized in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equitie ...

COHEN & STEERS REAL ESTATE OPPORTUNITIES & INCOME FUND 213 M $
Logo Cohen & Steers Real Estate Opportunities & Income Fund

Cohen & Steers Real Estate Opportunities & Income Fund (the Fund) is a non-diversified, closed-end management investment company. The Fund’s primary investment objective is high current income. The Fund’s secondary investment objective is capital appr ...

COHEN & STEERS QUALITY INCOME REALTY FUND, INC. 1 572 M $
Logo Cohen & Steers Quality Income Realty Fund, Inc.

Cohen & Steers Quality Income Realty Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's primary investment objective is high current income through investment in real estate securities. The Fund's secondary invest ...

COHEN & STEERS REIT AND PREFERRED INCOME FUND, INC. 982 M $
Logo Cohen & Steers REIT and Preferred Income Fund, Inc.

Cohen & Steers REIT and Preferred and Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is high current income. The Fund's secondary investment objective is capital appreciation. The F ...

COHEN & STEERS INFRASTRUCTURE FUND, INC 2 271 M $
Logo Cohen & Steers Infrastructure Fund, Inc

Cohen & Steers Infrastructure Fund, Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is total return, with an emphasis on income through investment in securities issued by infrastructure companies. U ...

COHEN & STEERS LIMITED DURATION PREFERRED AND INCOME FUND, INC. 571 M $
Logo Cohen & Steers Limited Duration Preferred and Income Fund, Inc.

Cohen & Steers Limited Duration Preferred & Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund’s primary investment objective is high current income. The Fund’s secondary investment objective is capital a ...

COHEN & STEERS SELECT PREFERRED AND INCOME FUND, INC. 231 M $
Logo Cohen & Steers Select Preferred and Income Fund, Inc.

Cohen & Steers Select Preferred and Income Fund, Inc. (the Fund) is a closed-end management investment company. The Fund’s primary investment objective is high current income. The Fund’s secondary investment objective is capital appreciation. It inves ...

COHEN & COMPANY INC. 17 M $
Logo Cohen & Company Inc.

Cohen & Company Inc. is a financial services company. The Company’s segments include Capital Markets, Asset Management, and Principal Investing. Capital Markets consists of fixed income sales, trading, and gestation repo financing as well as new issue p ...

COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. 322 M $
Logo Cohen & Steers Closed-End Opportunity Fund, Inc.

Cohen & Steers Closed-End Opportunity Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to achieve total return, consisting of high current income and potential capital appreciation. The F ...

COHEN & STEERS TOTAL RETURN REALTY FUND, INC. 309 M $
Logo Cohen & Steers Total Return Realty Fund, Inc.

Cohen & Steers Total Return Realty Fund, Inc. is a diversified, closed-end management investment company. The Fund's investment objective is to achieve a high total return through investment in real estate securities. The Fund seeks both current income an ...


12Next

Insiders


Picture Yuval Cohen
Yuval Cohen

Yuval Cohen is currently the Chief Financial Officer at Adika Style Ltd.
and Massivit 3D Printing Technologies Ltd.
He obtained his undergraduate degree from Tel-Aviv University in 1998.


Picture Yuval Cohen
Yuval Cohen

Yuval Cohen is the founder of Celsus Therapeutics Plc, which was founded in 2005.
He held the title of Director & Senior Vice President at Celsus Therapeutics Plc in 2013.
Currently, Dr. Cohen is the Chief Executive Officer & Director at Corbus Pharmaceuticals, Inc. since 2013 and the Chief Executive Officer & Director at Corbus Pharmaceuticals Holdings, Inc. since 2014.
Dr. Cohen's education includes an undergraduate degree from the University of Cape Town and a doctorate degree from Université de Paris 5 René Descartes.


Picture Yuval Cohen
Yuval Cohen

Yuval Cohen currently works at Firering Holdings Ltd., as Chief Executive Officer and Firering Strategic Minerals Plc, as Chief Executive Officer.
Mr. Cohen received his graduate degree from The College of Management Academic Studies.



Picture Yuval Cohen
Yuval Cohen

Yuval Cohen has a current job as a Director at Prothya Biosolutions Belgium BV.


Picture Yuval Cohen
Yuval Cohen

Yuval Cohen has founded Audio Pixels Ltd.
in 2006, where he holds the title of Chief Technology Officer.
Currently, he is the Chief Technical Officer at Audio Pixels Holdings Ltd.



Picture Yuval Cohen
Yuval Cohen

Yuval Cohen serves on Cyhawk’s Advisory Board.
He brings more than 17 years of experience in the venture capital market.
Yuval founded and manages Stage One Ventures, a venture capital fund focused on seed and early stage investments in the Information and Communications Technology sectors.
Prior to that he was a General Partner in Israel Infinity Fund, a $100 million Information Technology fund, where he was in charge of the Communications Sector.
Since 1995, Yuval has been involved, as an early stage investor and a director, in many young startups, some of which have already gone public or have been acquired by leading multinational companies.He has played an integral role in helping management teams recruit, develop strategies, and establish partnership agreements in many of his investees' companies.
Yuval served and still serves as a board member in multiple private and public companies including Traffix Systems, acquired by F5 (NASDAQ: FFIV), Trivnet, acquired by Gemalto (EPA:GTO), Guardium, acquired by IBM (NYSE:IBM), Radwiz, acquired by Terayon (NASDAQ:TERNE), Oridion Medical, acquired by Covidien (NYSE: COV), cVidya Networks, Oversi Networks, BI Science and OnGage.
Yuval earned his LLB and MBA degrees from the Hebrew University in Jerusalem.
When not at work, Yuval enjoys Tennis, skiing, traveling and hanging out with his family.


Picture Yuval Cohen
Yuval Cohen

Mr. Yuval Cohen is an Independent Director at Wix.com Ltd., a Chairman at Kornit Digital Ltd., a Chairman at Telrad Networks Ltd., a Founder & Managing Partner at Fortissimo Capital Management Ltd. and a Chairman at Solcon Industries Ltd. He is on the Board of Directors at Wix.com Ltd., Accord Insurance Agency Ltd., Animated Storyboards, Inc., GigaSpaces Technologies, Inc., Kramer Electronics Ltd, Otonomo Technologies Ltd., Phoenicia Flat Glass Industries Ltd., Priority Software Ltd., Sanquin Plasma Products BV, Synergy Cables Ltd., Tritone Technologies Ltd. and Tuttnauer Ltd. Mr. Cohen was previously employed as a Non-Executive Director by Emblaze Ltd., a Chairman by SodaStream International Ltd., a Partner by Jerusalem Venture Partners, a Principal by BreezeCOM Ltd., a President & Chief Executive Officer by Fortissimo Acquisition Corp., a Chairman by HBL- Hadasit Bio-Holdings Ltd., a Chairman by NUR Macroprinters Ltd., a Chairman by Soda-Club Holdings Ltd., a Chairman by Soda-Club Worldwide BV, a Chairman by Starhome Mach GmbH, a Non-Executive Director by Telit Communications Plc, and a Chairman by Telrad Networks Ltd. He also served on the board at Celltick Technologies, Inc., PowerDsine Ltd., Precise Software Solutions, Inc., Sheer Networks, Inc., TeleKnowledge Group Ltd., TSqware, Inc. and XMPie, Inc. He received his undergraduate degree from Tel-Aviv University and an MBA from Harvard Business School.

No results for this search